The Quinolones Global Market Report 2023, provides comprehensive information on the quinolones market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Quinolones Market’s Growth:
https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report
As per The Business Research Company’s Quinolones Global Market Report 2023, the global quinolones market size is expected to grow from $46.02 billion in 2022 to $48.09 billion in 2023 at a compound annual growth rate (CAGR) of 4.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global quinolones market size is expected to grow to $56.42 billion in 2027 at a CAGR of 4.1%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp
Product innovation is the key trend gaining popularity in the quinolones market. Major companies operating in the quinolones market are focusing on developing innovative products to sustain their market position. For instance, in January 2023, the South Korean branch of Viatris, a US-based pharmaceutical company launched Dovprela, a new drug-resistant tuberculosis treatment. Dovprela is a three-drug regimen of bedaquiline, pretomanid, and linezolid (BPaL) for treating adult patients with extensively drug-resistant TB and treatment-resistant or non-responsive multidrug-resistant TB. Dovprela reduces the treatment period from 18-20 months to 5-6 months due to its rapid anti-tuberculosis effect.
The quinolones market is segmented:
1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types
2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
North America was the largest region in the quinolones market in 2022.
The table of contents in TBRC’s quinolones market report includes:
- Executive Summary
- Quinolones Market Characteristics
- Quinolones Market Trends And Strategies
- Quinolones Market – Macro Economic Scenario
- Quinolones Market Size And Growth
.
.
.
- Africa Quinolones Market
- Quinolones Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Quinolones Market
- Quinolones Market Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
